Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Habal

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Surgical Oncology|January 3, 2001
Gastrointestinal carcinoid tumors and second primary malignanciesN Habal, C Sims, A J Bilchik
Seminars in Oncology|March 20, 2001
The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancerN Habal, A E Giuliano, D L Morton
Annals of Surgical Oncology|June 23, 2000
TA90-IC, a new marker for advanced colon cancerN Habal, R K Gupta, A J Bilchik, et al.
Annals of Surgical Oncology|June 16, 2001
CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancerN Habal, R K Gupta, A J Bilchik, et al.
Anticancer Research|November 4, 2000
Does human melanoma express carcinoembryonic antigen?M H Ravindranath, P Shen, N Habal, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever proteinJ G Ryan, S L Masters, M G Booty, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Surgical Oncology|January 3, 2001
Gastrointestinal carcinoid tumors and second primary malignanciesN Habal, C Sims, A J Bilchik
Seminars in Oncology|March 20, 2001
The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancerN Habal, A E Giuliano, D L Morton
Annals of Surgical Oncology|June 23, 2000
TA90-IC, a new marker for advanced colon cancerN Habal, R K Gupta, A J Bilchik, et al.
Annals of Surgical Oncology|June 16, 2001
CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancerN Habal, R K Gupta, A J Bilchik, et al.
Anticancer Research|November 4, 2000
Does human melanoma express carcinoembryonic antigen?M H Ravindranath, P Shen, N Habal, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever proteinJ G Ryan, S L Masters, M G Booty, et al.
Pageof 1